Neuropace, Inc. NPCE Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s accumulated depreciation?
- Neuropace, Inc. (NPCE) reported accumulated depreciation of $8.27M in Q1 2026.
- How has Neuropace, Inc.'s accumulated depreciation changed year-over-year?
- Neuropace, Inc.'s accumulated depreciation increased by 3.1% year-over-year, from $8.02M to $8.27M.
- What is the long-term trend for Neuropace, Inc.'s accumulated depreciation?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s accumulated depreciation has grown at a 0.1% compound annual growth rate (CAGR), from $8.16M to $8.21M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.